BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 19450526)

  • 1. Epigenetic silencing of the p16(INK4a) tumor suppressor is associated with loss of CTCF binding and a chromatin boundary.
    Witcher M; Emerson BM
    Mol Cell; 2009 May; 34(3):271-84. PubMed ID: 19450526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(ADP-ribosyl)ation regulates CTCF-dependent chromatin insulation.
    Yu W; Ginjala V; Pant V; Chernukhin I; Whitehead J; Docquier F; Farrar D; Tavoosidana G; Mukhopadhyay R; Kanduri C; Oshimura M; Feinberg AP; Lobanenkov V; Klenova E; Ohlsson R
    Nat Genet; 2004 Oct; 36(10):1105-10. PubMed ID: 15361875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SWI/SNF mediates polycomb eviction and epigenetic reprogramming of the INK4b-ARF-INK4a locus.
    Kia SK; Gorski MM; Giannakopoulos S; Verrijzer CP
    Mol Cell Biol; 2008 May; 28(10):3457-64. PubMed ID: 18332116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
    Hinshelwood RA; Melki JR; Huschtscha LI; Paul C; Song JZ; Stirzaker C; Reddel RR; Clark SJ
    Hum Mol Genet; 2009 Aug; 18(16):3098-109. PubMed ID: 19477956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct epigenetic domains separated by a CTCF bound insulator between the tandem genes, BLU and RASSF1A.
    Chang JW; Hsu HS; Ni HJ; Chuang CT; Hsiung CH; Huang TH; Wang YC
    PLoS One; 2010 Sep; 5(9):e12847. PubMed ID: 20877461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of the human retinoblastoma tumor suppressor gene promoter by CTCF.
    De La Rosa-Velázquez IA; Rincón-Arano H; Benítez-Bribiesca L; Recillas-Targa F
    Cancer Res; 2007 Mar; 67(6):2577-85. PubMed ID: 17363576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant methylation of RASSF1A is associated with poor survival in Tunisian breast cancer patients.
    Karray-Chouayekh S; Trifa F; Khabir A; Boujelbane N; Sellami-Boudawara T; Daoud J; Frikha M; Jlidi R; Gargouri A; Mokdad-Gargouri R
    J Cancer Res Clin Oncol; 2010 Feb; 136(2):203-10. PubMed ID: 19657672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H3K27 trimethylation is an early epigenetic event of p16INK4a silencing for regaining tumorigenesis in fusion reprogrammed hepatoma cells.
    Yao JY; Zhang L; Zhang X; He ZY; Ma Y; Hui LJ; Wang X; Hu YP
    J Biol Chem; 2010 Jun; 285(24):18828-37. PubMed ID: 20382980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen-mediated epigenetic repression of the imprinted gene cyclin-dependent kinase inhibitor 1C in breast cancer cells.
    Rodriguez BA; Weng YI; Liu TM; Zuo T; Hsu PY; Lin CH; Cheng AL; Cui H; Yan PS; Huang TH
    Carcinogenesis; 2011 Jun; 32(6):812-21. PubMed ID: 21304052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breaching the boundaries that safeguard against repression.
    Tiwari VK; Baylin SB
    Mol Cell; 2009 May; 34(4):395-7. PubMed ID: 19481516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(ADP-ribosyl)ation and epigenetics. Is CTCF PARt of the plot?
    Klenova E; Ohlsson R
    Cell Cycle; 2005 Jan; 4(1):96-101. PubMed ID: 15655363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic repression of RARRES1 is mediated by methylation of a proximal promoter and a loss of CTCF binding.
    Peng Z; Shen R; Li YW; Teng KY; Shapiro CL; Lin HJ
    PLoS One; 2012; 7(5):e36891. PubMed ID: 22615834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
    D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
    Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gain of DNA methylation is enhanced in the absence of CTCF at the human retinoblastoma gene promoter.
    Dávalos-Salas M; Furlan-Magaril M; González-Buendía E; Valdes-Quezada C; Ayala-Ortega E; Recillas-Targa F
    BMC Cancer; 2011 Jun; 11():232. PubMed ID: 21663659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased poly(ADP-ribosyl)ation of CTCF, a transcription factor, is associated with breast cancer phenotype and cell proliferation.
    Docquier F; Kita GX; Farrar D; Jat P; O'Hare M; Chernukhin I; Gretton S; Mandal A; Alldridge L; Klenova E
    Clin Cancer Res; 2009 Sep; 15(18):5762-71. PubMed ID: 19737964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.
    Schagdarsurengin U; Gimm O; Hoang-Vu C; Dralle H; Pfeifer GP; Dammann R
    Cancer Res; 2002 Jul; 62(13):3698-701. PubMed ID: 12097277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
    Nguyen CT; Gonzales FA; Jones PA
    Nucleic Acids Res; 2001 Nov; 29(22):4598-606. PubMed ID: 11713309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16INK4alpha tumor suppressor gene.
    Kotake Y; Cao R; Viatour P; Sage J; Zhang Y; Xiong Y
    Genes Dev; 2007 Jan; 21(1):49-54. PubMed ID: 17210787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic boundaries of tumour suppressor gene promoters: the CTCF connection and its role in carcinogenesis.
    Recillas-Targa F; De La Rosa-Velázquez IA; Soto-Reyes E; Benítez-Bribiesca L
    J Cell Mol Med; 2006; 10(3):554-68. PubMed ID: 16989720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells.
    Hong JA; Kang Y; Abdullaev Z; Flanagan PT; Pack SD; Fischette MR; Adnani MT; Loukinov DI; Vatolin S; Risinger JI; Custer M; Chen GA; Zhao M; Nguyen DM; Barrett JC; Lobanenkov VV; Schrump DS
    Cancer Res; 2005 Sep; 65(17):7763-74. PubMed ID: 16140944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.